BRIEF-Galapagos buys drug discovery firm Cangenix

BRUSSELS Tue Jan 15, 2013 1:35am EST

Related Topics

BRUSSELS Jan 15 (Reuters) - Galapagos NV : * Galapagos buys Cangenix, a structure-based drug discovery company * Says will pay a total cash consideration of 1 million pounds, with a further

440,000 pounds potential earn out payment

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.